DOCSLIB.ORG

Unbiased Phosphoproteomic Method Identifies the Initial Effects of a Methacrylic Acid Copolymer on Macrophages

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Unbiased Phosphoproteomic Method Identifies the Initial Effects of a Methacrylic Acid Copolymer on Macrophages Unbiased phosphoproteomic method identifies the initial effects of a methacrylic acid copolymer on macrophages Michael Dean Chamberlaina,1, Laura A. Wellsa,1,2, Alexandra Lisovskya, Hongbo Guob, Ruth Isserlinb, Ilana Talior-Volodarskya, Redouan Mahoua, Andrew Emilib, and Michael V. Seftona,c,3 aInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada M5S 3G9; bDonnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada M5S 3G9; and cDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada M5S 3G9 Edited by Robert Langer, Massachusetts Institute of Technology, Cambridge, MA, and approved July 21, 2015 (received for review May 5, 2015) An unbiased phosphoproteomic method was used to identify the potential to develop “rules of engagement” between cells and biomaterial-associated changes in the phosphorylation patterns of biomaterials. macrophage-like cells. The phosphorylation differences between This study investigated the effects of a methacrylic acid differentiated THP1 (dTHP1) cells treated for 10, 20, or 30 min with (MAA) copolymer on cells because these polymers have been a vascular regenerative methacrylic acid (MAA) copolymer or a shown to promote vascular regenerative responses in vivo (9, 10), control methyl methacrylate (MM) copolymer were determined by but the mechanism behind this response is unknown (11–13). MS. There were 1,470 peptides (corresponding to 729 proteins) Previous studies showed that 45% poly(MAA-co-methyl meth- that were differentially phosphorylated in dTHP1 cells treated acrylate [MM]) copolymer beads promoted vascularization and with the two materials with a greater cellular response to MAA improved wound healing in diabetic mice (10) or with skin grafts treatment. In addition to identifying pathways (such as integrin in rats (9). In vitro MAA beads altered the gene-expression signaling and cytoskeletal arrangement) that are well known to pattern in macrophage-differentiated THP1 cells (dTHP1) over change with cell–material interaction, previously unidentified path- 4 d (11). Recently, smooth copolymer films of isodecyl acrylate SCIENCES ways, such as apoptosis and mRNA splicing, were also discovered. (IDA) and MAA, or IDA and MM as a control, were studied APPLIED BIOLOGICAL (Fig. 1B); MAA films resulted in increased gene expression of phosphoproteomic | material–cell interactions | macrophage | IL-6, IL-1β, TNF-α, HIF-1α, and SDF-1α and decreased ex- methacrylic acid pression of osteopontin in dTHP1 cells (13), consistent with the previous bead work. conventional description of the interaction between cells Aand a material begins with protein adsorption (as affected Phosphorylation Changed with Time and Polymer Type by material chemistry or topography) that translates into the The dTHP1 cells were grown on porous transwell inserts and resulting effects on cell adhesion, migration, proliferation, or exposed to 40% MAA-co-IDA or 40% MM-co-IDA films by differentiation (1–3). This perspective is driven by the goal of placing polymer-coated coverslips on top of a monolayer of cells understanding biocompatibility (4) or of creating scaffolds for for 10, 20, or 30 min (Fig. 1C). The transwell insert allowed for tissue engineering. However, the complexity of these interactions nutrient and oxygen exchange between the cells and the medium limits the ability to understand and control the biological re- while in contact with the material; there were no obvious changes sponses to biomaterials, perhaps underscoring the occasional in cell morphology, as expected. After incubation with the failure of devices in the clinic (5). Furthermore, the metrics of the materials, the cells were lysed in urea buffer and the proteins conventional approach are often disconnected in time scale from the cellular response. Proteins adsorb in seconds, cell behavior Significance changes in hours, and biocompatibility is determined in days and weeks. The materials are agonists of the biological response, Cells interact with materials, such as those used in implants, whether it is an inflammatory response (6) or cell differentiation through an adsorbed protein layer that causes changes in cell (7, 8), but assays that focus on a particular time scale or pathway behavior and gene expression. We have identified the activa- risk missing the key determinants. The present study focuses on tion of signaling pathways in the cell by a material by unbiased the molecular changes that occur within 30 min of cell exposure to screening of changes in phosphorylation patterns in the cell a material, to identify the cell processes that happen between after material exposure to the material. These changes were recognition of protein adsorption and adaptation of the cell. apparent 10 min after exposure, filling the gap between the When cells contact a material (via adsorbed proteins), surface seconds of protein adsorption and the hours of gene expres- receptors are activated and downstream signaling cascades are sion and leading to the identification of hitherto unknown initiated. The activation of each receptor results in the initiation effects of materials on cells. of multiple signaling cascades that direct the biological response Author contributions: M.D.C., L.A.W., A.L., and M.V.S. designed research; M.D.C., L.A.W., A. of the cells to the material. Signaling cascades typically involve L., H.G., I.T.-V., and R.M. performed research; M.D.C., L.A.W., A.L., H.G., and R.I. analyzed kinases and phosphatases that change the phosphorylation patterns data; and M.D.C., L.A.W., A.L., A.E., and M.V.S. wrote the paper. of proteins to regulate downstream behaviors such as apoptosis, The authors declare no conflict of interest. gene expression, cytoskeletal rearrangement, and differentiation. This article is a PNAS Direct Submission. We hypothesized that the manner in which a material influences 1M.D.C. and L.A.W. contributed equally to this work. cell responses may be inferred by studying changes in the phos- 2Present address: Department of Chemical Engineering, Queen’s University, Kingston, ON, phorylation events of the intracellular signaling cascades (Fig. 1A). Canada K7L 3N6. This work used phosphoproteomics to detect, in an unbiased 3To whom correspondence should be addressed. Email: [email protected]. manner, actively phosphorylated proteins in cells exposed to two This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. different materials to identify novel interactions. Ultimately, we see 1073/pnas.1508826112/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1508826112 PNAS Early Edition | 1of6 Downloaded by guest on September 23, 2021 A MAA biomaterial In vivo response Jak p granulation tissue PI3K p vessel Akt p MAA biomaterial Material properties: Biological response: Topography Gene expression Charge Protein expression Elasticity Cell viability Phosphorylation cascade Porosity Cell morphology Chemical groups Proliferation In vivo response B D T260 T303 S259 S301 S357 RAF1 protein T258 S296 Y341 S257 S295 Y340 S43 S252 S291 S339 S642 S29 S244 S289 S338 S621 RBD C1_1 Pkinase_Tyr zf-RING-like Digested S301 S301 S43 S252 S295 S296 S621 C Enriched by TiO2 magnetic S301 S301 dTHP1 Biomaterial S43 S252 S295 S296 S621 (10, 20 & 30 min) Cell lysate Known function Unknown funciton Ex. S259, S296, T491, T494 Ex. Y38, S295 p-Peptide analysis Activating Inhibiting Ex. T491, T494 Ex. S259, S296 1,470 p-Peptide changes 729 p-Proteins changes Fig. 1. Overview of phosphoproteomic method to assess the effects of materials on biological responses. (A) Biological responses (e.g., gene expression, cell proliferation, in vivo host response) are related to material properties (e.g., topography or chemistry) through phosphorylation signaling cascades. The properties of the material govern how proteins from the extracellular milieu adsorb to the surface of the biomaterial and are presented to the cell. These proteins activate the signaling phosphorylation cascades within the cell that drive the biological response to the material. (B) Films containing MAA or MM copolymerized with IDA were cast onto the underside of glass coverslips. (C) Coverslips coated with 40% MAA or 40% MM films were placed on serum- starved dTHP1 cells for 10, 20, or 30 min (with films lying atop cells in a Transwell insert), after which the cells were lysed with urea buffer. The cell lysate was digested with trypsin and the phosphorylated peptides were enriched from the cell lysate by TiO2 magnetic beads and analyzed by MS. (D) Phosphorylated peptides from proteins (RAF-1 is shown as an example) were enriched and identified by MS. Peptides were sorted based on the function of the phosphor- ylation site. Some proteins had a known function of the phosphorylation site that was further distinguished by literature review; other phosphorylation sites had no known function. digested with trypsin. The phosphopeptides were enriched from method for the enrichment of phosphopeptides. In general, there the total peptide mixture by TiO2 magnetic beads and identified were three types of phosphorylations that were identified in this by using an Orbitrap Velos mass spectrometer coupled with screen: (i) phosphorylations that are known to promote the ac- separation via an inline nano-HPLC (14). tivity of the protein, (ii) phosphorylations that are known to inhibit Peptide lists were generated from the MS data by using the activity of the protein,
Load more

Recommended publications
  • (BCLAF1) ELISA Kit Catalogue No.:Abx503645
    Datasheet Version: 1.0.0 Revision date: 14 Jan 2021 Human Bcl-2-associated transcription factor 1 (BCLAF1) ELISA Kit Catalogue No.:abx503645 Human Bcl-2-associated transcription factor 1 (BCLAF1) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Bcl-2-associated transcription factor 1 (BCLAF1) concentrations in tissue homogenates, cell lysates and other biological fluids. Target: Bcl-2-associated transcription factor 1 (BCLAF1) Reactivity: Human Tested Applications: ELISA Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user. Storage: Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual. Validity: The validity for this kit is 6 months. Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout. UniProt Primary AC: Q9NYF8 (UniProt, ExPASy) Gene Symbol: ForBCLAF1 Reference Only KEGG: hsa:9774 Test Range: 0.156 ng/ml - 10 ng/ml Standard Form: Lyophilized ELISA Detection: Colorimetric v1.0.0 Abbexa Ltd, Cambridge, UK · Phone: +44 1223 755950 · Fax: +44 1223 755951 1 Abbexa LLC, Houston, TX, USA · Phone: +1 832 327 7413 www.abbexa.com · Email: [email protected] Datasheet Version: 1.0.0 Revision date: 14 Jan 2021 ELISA Data: Quantitative Sample Type: Tissue homogenates, cell lysates and other biological fluids. Note: This product is for research use only.
    [Show full text]
  • ATRX Protects Cells Against Replication-Induced Genomic Instability
    ATRX Protects Cells Against Replication-Induced Genomic Instability Danton Ivanochko M.Sc. Thesis This thesis is submitted to the Faculty of Graduate and Postdoctoral Studies in partial fulfillment of the requirements for the degree of Master of Science in Biochemistry with a specialization in Human and Molecular Genetics Department of Biochemistry, Microbiology, and Immunology Faculty of Medicine University of Ottawa, Ontario, Ontario, Canada © Danton Ivanochko, Ottawa, Canada, 2016 Dedicated to my parents. ii Abstract Expansive proliferation of neural progenitor cells (NPCs) is a prerequisite to the temporal waves of neuronal differentiation that generate the six-layered cerebral cortex. NPC expansion places a heavy burden on proteins that regulate chromatin packaging and genome integrity, which is further reflected by the growing number of developmental disorders caused by mutations in chromatin regulators. Accordingly, mutations in ATRX, a chromatin remodelling protein required for heterochromatin maintenance at telomeres and simple repeats, cause the ATR-X syndrome. Here, we demonstrate that proliferating ATRX-null cells accumulate DNA damage, while also exhibiting sensitivity to hydroxyurea-induced replication fork stalling. Specifically, PARP1 hyperactivation and replication-dependent double strand DNA breakage indicated replication fork protection defects, while DNA fiber assays confirmed that ATRX was required to protect replication forks from degradation. Interestingly, inhibition of the exonuclease MRE11 by the small molecule mirin could prevent degradation. Thus, ATRX is required to limit replication stress during NPC expansion. iii Acknowledgements First and foremost, I would like to thank my supervisor, Dr. David Picketts, for his guidance and support during my undergraduate and graduate studies. Thanks to the members of my thesis advisory committee, Dr.
    [Show full text]
  • Link to Dr. Hunter's Slides
    Making Sense of the Science of WM Zachary Hunter Bing Center for WM Dana-Farber Cancer Institute Harvard Medical School Bing Center for WM Harvard Research at the Medical Dana-Farber School Cancer Institute e Bing Center for WM Research at the Dana-Farber Cancer Institute Understanding Genetics If you only had four letters to work with, what kind of story could you tell? Genomics is easy… ➢ Deoxyribonucleic Acid (DNA) is made of complex molecules called nucleotides. There are 4 types abbreviated A,T,C,G. ➢ Nucleotide bases form stables pairs: A-T and C-G. Two complimentary strands of these bases form DNA. ➢ DNA is broken into 23 long strands known as chromosomes. ➢ The sections of the DNA that contain instructions on how to build proteins are called genes. ➢ Genes in the DNA are transcribed into a single strand of similar nucleotides called Ribonucleic Acid (RNA) and this “message” is processed by the cell and turned into protein. Something easy with ~ 3,000,000,000 pieces can be really complicated… For context, computers operate with just two “bases” 0 and 1. With enough 0s and 1s it turns out you can make computer’s do some pretty impressive and complicated stuff. DNA has 4 bases, x 3 Billion with a lot more chemical and spatial annotation. This makes IBM’s Watson look simple by comparison, even if it does beat us at Jeopardy DNA – RNA – Protein • Transcribed • Stores Provides from DNA information structure, • Encodes signaling, • Used as a instructions and carries template to make out most for RNA protein cellular work • Genes are regions of the DNA that are transcribed into RNA • RNA carries the DNA code out into the rest of the cell where it can be used as instructions to make protein How to make it all fit… 3 billion base pairs strung end to end is about 40 inches in length.
    [Show full text]
  • Patient Mutations Alter ATRX Targeting to PML Nuclear Bodies
    European Journal of Human Genetics (2008) 16, 192–201 & 2008 Nature Publishing Group All rights reserved 1018-4813/08 $30.00 www.nature.com/ejhg ARTICLE Patient mutations alter ATRX targeting to PML nuclear bodies Nathalie G Be´rube´1,3,4, Jasmine Healy1,4, Chantal F Medina1, Shaobo Wu1, Todd Hodgson1, Magdalena Jagla1 and David J Picketts*,2 1Molecular Medicine Program, Ottawa Health Research Institute, Ottawa, Ontario, Canada; 2Departments of Medicine and Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Ontario, Canada ATRX is a SWI/SNF-like chromatin remodeling protein mutated in several X-linked mental retardation syndromes. Gene inactivation studies in mice demonstrate that ATRX is an essential protein and suggest that patient mutations likely retain partial activity. ATRX associates with the nuclear matrix, pericentromeric heterochromatin, and promyelocytic leukemia nuclear bodies (PML-NBs) in a speckled nuclear staining pattern. Here, we used GFP–ATRX fusion proteins to identify the specific domains of ATRX necessary for subnuclear targeting and the effect of patient mutations on this localization. We identified two functional nuclear localization signals (NLSs) and two domains that target ATRX to nuclear speckles. One of the latter domains is responsible for targeting ATRX to PML-NBs. Surprisingly, this domain encompassed motifs IV–VI of the SNF2 domain suggesting that in addition to chromatin remodeling, it may also have a role in subnuclear targeting. More importantly, four different patient mutations within this domain resulted in an B80% reduction in the number of transfected cells with ATRX nuclear speckles and PML colocalization. These results demonstrate that patient mutations have a dramatic effect on subnuclear targeting to PML-NBs.
    [Show full text]
  • X-Linked Diseases: Susceptible Females
    REVIEW ARTICLE X-linked diseases: susceptible females Barbara R. Migeon, MD 1 The role of X-inactivation is often ignored as a prime cause of sex data include reasons why women are often protected from the differences in disease. Yet, the way males and females express their deleterious variants carried on their X chromosome, and the factors X-linked genes has a major role in the dissimilar phenotypes that that render women susceptible in some instances. underlie many rare and common disorders, such as intellectual deficiency, epilepsy, congenital abnormalities, and diseases of the Genetics in Medicine (2020) 22:1156–1174; https://doi.org/10.1038/s41436- heart, blood, skin, muscle, and bones. Summarized here are many 020-0779-4 examples of the different presentations in males and females. Other INTRODUCTION SEX DIFFERENCES ARE DUE TO X-INACTIVATION Sex differences in human disease are usually attributed to The sex differences in the effect of X-linked pathologic variants sex specific life experiences, and sex hormones that is due to our method of X chromosome dosage compensation, influence the function of susceptible genes throughout the called X-inactivation;9 humans and most placental mammals – genome.1 5 Such factors do account for some dissimilarities. compensate for the sex difference in number of X chromosomes However, a major cause of sex-determined expression of (that is, XX females versus XY males) by transcribing only one disease has to do with differences in how males and females of the two female X chromosomes. X-inactivation silences all X transcribe their gene-rich human X chromosomes, which is chromosomes but one; therefore, both males and females have a often underappreciated as a cause of sex differences in single active X.10,11 disease.6 Males are the usual ones affected by X-linked For 46 XY males, that X is the only one they have; it always pathogenic variants.6 Females are biologically superior; a comes from their mother, as fathers contribute their Y female usually has no disease, or much less severe disease chromosome.
    [Show full text]
  • Structure of the SWI2/SNF2 Chromatin-Remodeling Domain of Eukaryotic Rad54
    ARTICLES Structure of the SWI2/SNF2 chromatin-remodeling domain of eukaryotic Rad54 Nicolas H Thomä1, Bryan K Czyzewski1,2, Andrei A Alexeev3, Alexander V Mazin4, Stephen C Kowalczykowski3 & Nikola P Pavletich1,2 SWI2/SNF2 chromatin-remodeling proteins mediate the mobilization of nucleosomes and other DNA-associated proteins. SWI2/SNF2 proteins contain sequence motifs characteristic of SF2 helicases but do not have helicase activity. Instead, they couple ATP hydrolysis with the generation of superhelical torsion in DNA. The structure of the nucleosome-remodeling domain of zebrafish Rad54, a protein http://www.nature.com/nsmb involved in Rad51-mediated homologous recombination, reveals that the core of the SWI2/SNF2 enzymes consist of two ␣/␤-lobes similar to SF2 helicases. The Rad54 helicase lobes contain insertions that form two helical domains, one within each lobe. These insertions contain SWI2/SNF2-specific sequence motifs likely to be central to SWI2/SNF2 function. A broad cleft formed by the two lobes and flanked by the helical insertions contains residues conserved in SWI2/SNF2 proteins and motifs implicated in DNA-binding by SF2 helicases. The Rad54 structure suggests that SWI2/SNF2 proteins use a mechanism analogous to helicases to translocate on dsDNA. Cellular processes such as transcription, replication, DNA repair and breaks by Rad51-mediated homologous recombination15–20. Like other recombination require direct access to DNA. This process is facilitated SWI2/SNF2 remodeling enzymes, Rad54 can translocate on DNA, gen- by the SWI2/SNF2 family of ATPases, which detach DNA from histones erate superhelical torsion and enhance the accessibility to nucleosomal and other bound proteins1,2. The SWI2/SNF2 chromatin remodeling DNA18,19,21.
    [Show full text]
  • Downloaded with Ma- Disease D D
    bioRxiv preprint doi: https://doi.org/10.1101/483065; this version posted November 29, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. F1000Research 2016 - DRAFT ARTICLE (PRE-SUBMISSION) Bioinformatics Approach to Identify Diseasome and Co- morbidities Effect of Mitochondrial Dysfunctions on the Progression of Neurological Disorders Md. Shahriare Satu1, Koushik Chandra Howlader2, Tajim Md. Niamat Ullah Akhund3, Fazlul Huq4, Julian M.W. Quinn5, and Mohammad Ali Moni4,5 1Dept. of CSE, Gono Bishwabidyalay, Dhaka, Bangladesh 2Dept. of CSTE, Noakhali Science and Technology University, Noakhali, Bangladesh 3Institute of Information Technology, Jahangirnagar University, Dhaka, Bangladesh 4School of Biomedical Science, Faculty of Medicine and Health, The University of Sydney, Australia 5Bone Biology Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia Abstract Mitochondrial dysfunction can cause various neurological diseases. We therefore developed a quantitative framework to explore how mitochondrial dysfunction may influence the progression of Alzheimer’s, Parkinson’s, Hunting- ton’s and Lou Gehrig’s diseases and cerebral palsy through analysis of genes showing altered expression in these conditions. We sought insights about the gene profiles of mitochondrial and associated neurological diseases by investigating gene-disease networks, KEGG pathways, gene ontologies and protein-protein interaction network. Gene disease networks were constructed to connect shared genes which are commonly found between the neurological diseases and Mito- chondrial Dysfunction. We also generated KEGG pathways and gene ontologies to explore functional enrichment among them, and protein-protein interaction networks to identify the shared protein groups of these diseases.
    [Show full text]
  • ATRX-Mutant Cancers to WEE1 Inhibition Junbo Liang1, Hong Zhao2,3, Bill H
    Published OnlineFirst September 24, 2019; DOI: 10.1158/0008-5472.CAN-18-3374 CANCER RESEARCH | TRANSLATIONAL SCIENCE Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition Junbo Liang1, Hong Zhao2,3, Bill H. Diplas4, Song Liu5, Jianmei Liu2,3, Dingding Wang1, Yan Lu1, Qing Zhu6, Jiayu Wu1, Wenjia Wang1, Hai Yan4, Yi-Xin Zeng6, Xiaoyue Wang1, and Yuchen Jiao2,7 ABSTRACT ◥ The tumor suppressor gene ATRX is frequently mutated in a induced apoptosis. AZD1775 also selectively inhibited the prolif- variety of tumors including gliomas and liver cancers, which are eration of patient-derived primary cell lines from gliomas with highly unresponsive to current therapies. Here, we performed a naturally occurring ATRX mutations, indicating that the synthetic genome-wide synthetic lethal screen, using CRISPR-Cas9 genome lethal relationship between WEE1 and ATRX could be exploited in a editing, to identify potential therapeutic targets specific for ATRX- broader spectrum of human tumors. As WEE1 inhibitors have been mutated cancers. In isogenic hepatocellular carcinoma (HCC) cell investigated in several phase II clinical trials, our discovery provides lines engineered for ATRX loss, we identified 58 genes, including the the basis for an easily clinically testable therapeutic strategy specific checkpoint kinase WEE1, uniquely required for the cell growth of for cancers deficient in ATRX. ATRX null cells. Treatment with the WEE1 inhibitor AZD1775 robustly inhibited the growth of several ATRX-deficient HCC cell Significance: ATRX-mutant cancer cells depend on WEE1, lines in vitro, as well as xenografts in vivo. The increased sensitivity which provides a basis for therapeutically targeting WEE1 in to the WEE1 inhibitor was caused by accumulated DNA damage– ATRX-deficient cancers.
    [Show full text]
  • ATRX and RECQ5 Define Distinct Homologous Recombination Subpathways
    ATRX and RECQ5 define distinct homologous recombination subpathways Amira Elbakrya, Szilvia Juhásza,1, Ki Choi Chana, and Markus Löbricha,2 aRadiation Biology and DNA Repair, Technical University of Darmstadt, 64287 Darmstadt, Germany Edited by Stephen C. West, The Francis Crick Institute, London, United Kingdom, and approved December 10, 2020 (received for review May 25, 2020) Homologous recombination (HR) is an important DNA double- or by the resolvase GEN1 which induce asymmetrical or sym- strand break (DSB) repair pathway that copies sequence informa- metrical incisions in the two strands at each HJ, giving rise to tion lost at the break site from an undamaged homologous tem- both crossover (CO) and non-CO products (6–8). Additionally, plate. This involves the formation of a recombination structure dHJs can be dissolved by the BLM/TOPOIIIα/RMI1/2 (BTR) that is processed to restore the original sequence but also harbors complex, where the two HJs migrate toward each other and the potential for crossover (CO) formation between the participat- merge to form a hemicatenane that is then decatenated by top- ing molecules. Synthesis-dependent strand annealing (SDSA) is an oisomerases, thus separating the two molecules without ex- HR subpathway that prevents CO formation and is thought to change of genetic material (9–11). Under specific circumstances, predominate in mammalian cells. The chromatin remodeler ATRX a third subpathway termed break-induced replication (BIR) can promotes an alternative HR subpathway that has the potential to mediate conservative DNA synthesis initiated by the D-loop to form COs. Here, we show that ATRX-dependent HR outcompetes copy the entire chromosome arm (12, 13).
    [Show full text]
  • The Chromatin Remodeller ATRX: a Repeat Offender in Human Disease
    Review The chromatin remodeller ATRX: a repeat offender in human disease David Clynes, Douglas R. Higgs, and Richard J. Gibbons MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK The regulation of chromatin structure is of paramount collaboration with its interaction partner death-associated importance for a variety of fundamental nuclear process- protein 6 (DAXX), functions as a histone chaperone complex es, including gene expression, DNA repair, replication, for the deposition of the histone variant H3.3 into peri- and recombination. The ATP-dependent chromatin- centric, telomeric, and ribosomal repeat sequences [7–10]. remodelling factor ATRX (a thalassaemia/mental retar- ATR-X syndrome is characterised by a variety of clini- dation X-linked) has emerged as a key player in each of cal features that include mental retardation, facial, skel- these processes. Exciting recent developments suggest etal, and urogenital abnormalities, as well as mild a- that ATRX plays a variety of key roles at tandem repeat thalassaemia (a blood disorder characterised by an im- sequences within the genome, including the deposition balance of globin chain synthesis and anaemia) [11,12]. of a histone variant, prevention of replication fork stal- The latter is attributable to reduced expression of the a ling, and the suppression of a homologous recombina- globin genes located on chromosome 16. ATRX was hence tion-based pathway of telomere maintenance. Here, we considered to be an X-chromosome-encoded trans-acting provide a mechanistic overview of the role of ATRX in factor that facilitates the expression of a select repertoire each of these processes, and propose how they may be of disparate genes.
    [Show full text]
  • ATRX Promotes Heterochromatin Formation to Protect Cells from G-Quadruplex DNA-Mediated Stress
    ARTICLE https://doi.org/10.1038/s41467-021-24206-5 OPEN ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress Yu-Ching Teng1, Aishwarya Sundaresan1, Ryan O’Hara1, Vincent U. Gant1, Minhua Li1, Sara Martire 1, ✉ Jane N. Warshaw1, Amrita Basu2 & Laura A. Banaszynski 1 1234567890():,; ATRX is a tumor suppressor that has been associated with protection from DNA replication stress, purportedly through resolution of difficult-to-replicate G-quadruplex (G4) DNA structures. While several studies demonstrate that loss of ATRX sensitizes cells to chemical stabilizers of G4 structures, the molecular function of ATRX at G4 regions during replication remains unknown. Here, we demonstrate that ATRX associates with a number of the MCM replication complex subunits and that loss of ATRX leads to G4 structure accumulation at newly synthesized DNA. We show that both the helicase domain of ATRX and its H3.3 chaperone function are required to protect cells from G4-induced replicative stress. Fur- thermore, these activities are upstream of heterochromatin formation mediated by the his- tone methyltransferase, ESET, which is the critical molecular event that protects cells from G4-mediated stress. In support, tumors carrying mutations in either ATRX or ESET show increased mutation burden at G4-enriched DNA sequences. Overall, our study provides new insights into mechanisms by which ATRX promotes genome stability with important impli- cations for understanding impacts of its loss on human disease. 1 Cecil H. and Ida Green Center for Reproductive Biology Sciences, Department of Obstetrics and Gynecology, Children’s Medical Center Research Institute, Harold. C. Simmons Comprehensive Cancer Center, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical ✉ Center, Dallas, TX, USA.
    [Show full text]
  • Anti-BCLAF1 / BTF Antibody (ARG11032)
    Product datasheet [email protected] ARG11032 Package: 100 μg anti-BCLAF1 / BTF antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes BCLAF1 / BTF Tested Reactivity Hu Tested Application IP, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name BCLAF1 / BTF Antigen Species Human Immunogen Recombinant His-tagged protein fragment of Human BCLAF1 / BTF. Conjugation Un-conjugated Alternate Names Bcl-2-associated transcription factor 1; Btf; BTF; bK211L9.1 Application Instructions Application table Application Dilution IP Assay-dependent WB 1:1000 - 1:3000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 106 kDa Properties Form Liquid Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol BCLAF1 Gene Full Name BCL2-associated transcription factor 1 Background This gene encodes a transcriptional repressor that interacts with several members of the BCL2 family of www.arigobio.com 1/2 proteins. Overexpression of this protein induces apoptosis, which can be suppressed by co-expression of BCL2 proteins. The protein localizes to dot-like structures throughout the nucleus, and redistributes to a zone near the nuclear envelope in cells undergoing apoptosis. Multiple transcript variants encoding different isoforms have been found for this gene.
    [Show full text]